Agenda and speaker bios for Fogarty 50th Anniversary Symposium: What are the new frontiers in global health research?

The Fogarty International Center at NIH is celebrating our 50th anniversary. To mark this milestone, Fogarty held a 50th anniversary symposium, "What are the new frontiers in global health research?" on May 1, 2018.

Fogarty at 50 

Sponsored by:

Foundation for the NIH logo 

With support from:

Bharat Biotech logo - Lead Innovation 

ICAP logo - Columbia University Mailman School of Public Health 

Medtronic Foundation 

Merck logo 

Pfizer logo
Tulane University School of Public Health and Tropical Medicine logo 

Agenda

Welcome
[Watch this Session]

Dr. Roger I. Glass (bio)
Director, Fogarty International Center

Keynote: "When History Quickens Its Pace: From Fogarty To Fortune"
[Watch this Session]

Dr. Richard Horton (bio)
Editor, The Lancet

Topic One: What has been accomplished and what is needed to advance infectious disease research and actually achieve the end of AIDS?
[Watch this Session]

  • Dr. Anthony S. Fauci, moderator (bio)
    Director, National Institute of Allergy and Infectious Diseases (NIAID)
  • Dr. Quarraisha Abdool Karim (bio)
    Associate Scientific Director, CAPRISA, South Africa
  • Dr. Bill Pape (bio)
    Director, GHESKIO, Haiti
  • Dr. Linda-Gail Bekker (bio)
    President, International AIDS Society
    Deputy Director, Desmond Tutu HIV Centre, University of Cape Town
  • Dr. Sten H. Vermund (bio)
    Dean, Yale University School of Public Health

Remarks
[Watch this Session]

Senator Jack Reed (bio)

How can NIH Institutes and Centers collectively sustain and advance the global health research agenda?
[Watch this Session]

Dr. Francis S. Collins (bio)
NIH Director

Topic two: Noncommunicable diseases: how can we leverage existing research and training platforms to stem the tide of deaths and disability?
[Watch this Session]

  • Overview:
    • Dr. Glenda Gray, moderator (bio)
      Chair, Global Alliance for Chronic Diseases, former Fogarty trainee
      President and CEO, South African Medical Research Council
  • Cancer:
    • Dr. Douglas R. Lowy (bio)
      Deputy Director, National Cancer Institute (NCI)
    • Dr. Satish Gopal (bio)
      NCI grantee, former Fogarty grantee and Fellow
      University of North Carolina
      Malawi's only medical oncologist and Cancer Director of the UNC Project-Malawi
    • Dr. Sam Phiri (bio)
      NCI grantee and mentor of Fogarty Fellows and Scholars
      Director and Principal Investigator, Lighthouse Trust Clinic, Malawi
  • Cardiology, Sickle Cell Disease:
    • Dr. Gary H. Gibbons (bio)
      Director, National Heart, Lung and Blood Institute (NHLBI)
    • Dr. Julie Makani (bio)
      NHLBI grantee, Associate Professor and Principal Investigator, Sickle Cell Programme, Muhimbili University of Health and Allied Sciences, Tanzania
    • Dr. Gerald Bloomfield (bio)
      Fogarty Fellow and cardiologist/assistant professor, Duke University and Moi University, Kenya

Topic three: Global Brain Disorders: we're on the agenda, where do we go from here? What are the priorities for advancing the global mental health research agenda?
[Watch this Session]

  • Dr. Peter Kilmarx, moderator (bio)
    Deputy Director, Fogarty International Center
  • Case study: stigma and epilepsy in LMICs
    • Dr. Walter J. Koroshetz (bio)
      Director, National Institute of Neurological Disorders and Stroke (NINDS)
    • Dr. Gretchen L. Birbeck (bio)
      NINDS/Fogarty grantee and professor, University of Rochester
  • Case study: family with early-onset Alzheimer's in Colombia may hold key to cure
    • Dr. Richard J. Hodes (bio)
      Director, National Institute on Aging (NIA)
    • Dr. Kenneth S. Kosik (bio)
      NIA/Fogarty grantee, University of California, Santa Barbara
  • Case study: genomics studies of schizophrenia in LMICs
    • Dr. Shelli Avenevoli (bio)
      Deputy Director, National Institute of Mental Health (NIMH)
    • Dr. Vishwajit Nimgaonkar (bio)
      NIMH/Fogarty grantee, University of Pittsburgh

Topic four: Multigenerational models of long-term capacity building: the trainees become the trainers
[Watch this Session]

  • Dr. Roger I. Glass, moderator (bio)
    Director, Fogarty International Center
  • Dr. Patricia Garcia (bio)
    Cayetano Heredia University, Peru
    Trainee: Dr. Magaly Blas (bio)
  • Dr. Salim "Slim” Abdool Karim (bio)
    CAPRISA Director, South Africa
    Trainee: Dr. Vivek Naranbhai (bio)
  • Dr. Nelson Sewankambo (bio)
    Makerere University, Uganda
    Trainee: Dr. Mark Kaddumukasa (bio)

Concluding Remarks
[Watch this Session]

Dr. Roger I. Glass
Director, Fogarty International Center

Speaker Bios

Dr. Quarraisha Abdool Karim
Associate Scientific Director, CAPRISA, South Africa
A world-renowned scientist and infectious disease epidemiologist, Dr. Quarraisha Abdool Karim is associate scientific director for the Centre for the AIDS Programme of Research in South Africa (CAPRISA). A professor at the University of KwaZulu-Natal and Columbia University, her research focuses on understanding the HIV epidemic in South Africa, factors influencing HIV infection in adolescent girls, and sustainable strategies to introduce antiretroviral therapy in resource-constrained settings. She has won numerous honors for her seminal scientific contributions and, as a Fogarty grantee, has helped train a generation of African scientists.

Dr. Salim "Slim" Abdool Karim
Director, CAPRISA, South Africa
Dr. Salim Abdool Karim, a longtime NIH and Fogarty grantee, is a clinical infectious disease epidemiologist recognized for his groundbreaking contributions to HIV prevention research. He is director of the Centre for the AIDS Programme of Research in South Africa (CAPRISA), pro vice-chancellor at the University of KwaZulu-Natal, and on the faculty of Columbia and Cornell Universities. He has conducted landmark research on microbicides for HIV prevention, is co-inventor on patents used in several HIV vaccine candidates, and his research on TB-HIV treatment shaped international guidelines on the clinical management of co-infected patients.

Dr. Shelli Avenevoli
Deputy Director, National Institute of Mental Health, NIH
Dr. Shelli Avenevoli was named deputy director of NIH's National Institute of Mental Health (NIMH) in 2017. With a background in developmental science and epidemiology, she joined the Institute as a staff scientist in 2001 and moved from the intramural to extramural program where she ultimately led the Developmental Trajectories of Mental Disorders Branch. She has been involved in several key efforts, including revising the Institute's strategic plan, redefining its approach to supporting research in neurodevelopment and bipolar disorder, and serving as a liaison to other agencies.

^ Agenda

Dr. Linda-Gail Bekker
President, International AIDS Society
Deputy Director, Desmond Tutu HIV Centre, University of Cape Town
A former Fogarty trainee, Dr. Linda-Gail Bekker is a professor of medicine at the University of Cape Town (UCT), deputy director of the Desmond Tutu HIV Centre at UCT's Institute of Infectious Disease and Molecular Medicine, and chief operating officer of the Desmond Tutu HIV Foundation, a nonprofit that works to improve the well-being of people from some of South Africa's poorest communities. A physician-scientist interested in HIV, tuberculosis and related diseases, Dr. Bekker is president of the International AIDS Society and serves on numerous other committees and boards.

Dr. Gretchen L. Birbeck
Professor, University of Rochester
A member of Fogarty's advisory board, Dr. Gretchen Birbeck's research focuses on neurologic disorders in resource-limited tropical settings. Since 1994, she has provided clinical care and conducted research on epilepsy and related stigma in sub-Saharan Africa, primarily Zambia. Dr. Birbeck is a professor at the University of Rochester and research director of the Strong Epilepsy Center. She also holds positions with the University of Zambia and Queen Elizabeth Central Hospital in Malawi. Her research funders include NIH's National Institute of Neurological Disorders and Stroke (NINDS) and Fogarty.

Dr. Magaly Blas
Associate Professor, Cayetano Heredia University, Peru
Dr. Magaly Blas has been a Fogarty Scholar, Fellow and grantee, and is an associate professor at Cayetano Heredia University in Lima, Peru. She has conducted research on the epidemiology of HIV, HPV and other sexually transmitted infections, and studied the use of information and communication technologies to prevent HIV, and improve maternal and child health in remote areas in the Amazon. She received advanced epidemiology training through a Fogarty program at the University of Washington and remains affiliated with the institution.

^ Agenda

Dr. Gerald Bloomfield
Assistant Professor, Duke University
A former Fogarty Fellow, Dr. Gerald Bloomfield is an assistant professor of medicine and global health at Duke University. He launched a clinical research program at Moi University in Eldoret, Kenya to determine the causes of heart failure among East Africans, with support from a Fogarty award for early career scientists, in partnership with NIH's National Heart, Lung and Blood Institute (NHLBI). Dr. Bloomfield's research interests include cardiovascular medicine, echocardiography, global health, and noncommunicable diseases associated with HIV.

Dr. Francis S. Collins
Director, NIH
Dr. Francis S. Collins has served as director of the National Institutes of Health since 2009. Originally appointed by President Obama, Dr. Collins was asked by President Trump to continue in his position. Dr. Collins is a physician-geneticist noted for his landmark discoveries of disease genes and his leadership of the international Human Genome Project. As NIH director, he has forged a collaboration with the Bill & Melinda Gates Foundation and established two cross-cutting global health programs - the Medical Education Partnership Initiative (MEPI) and the Human Heredity and Health in Africa (H3Africa) project.

Dr. Anthony S. Fauci
Director, National Institute of Allergy and Infectious Diseases, NIH
Dr. Anthony S. Fauci has led NIH's National Institute of Allergy and Infectious Diseases (NIAID) since 1984, overseeing a portfolio of basic and applied research to prevent, diagnose and treat established infectious diseases such as HIV/AIDS, respiratory infections, diarrheal diseases, tuberculosis and malaria, as well as emerging diseases including Ebola and Zika. He has advised five Presidents on HIV/AIDS and other domestic and global health issues. He was one of the principal architects of the President's Emergency Plan for AIDS Relief (PEPFAR), a program that has saved millions of lives throughout the developing world.

^ Agenda

Dr. Patricia García
Professor, School of Public Health, Cayetano Heredia University, Peru
Longtime Fogarty grantee Dr. Patty García received advanced training with Fogarty support early in her career and is now professor of the School of Public Health at Cayetano Heredia University (UPCH) in Lima, Peru. She recently served as Peru's health minister and was previously chief of her country's National Institute of Health. Dr. Garcia is also affiliated with the University of Washington and Tulane University. She has been a leader in incorporating technology into health research and is actively involved in research and training on STI/HIV, global health and HPV.

Dr. Gary H. Gibbons
Director, National Heart, Lung and Blood Institute, NIH
Since 2012, Dr. Gary H. Gibbons has been director of the National Heart, Lung, and Blood Institute (NHLBI), the NIH's third largest institute. NHLBI provides global leadership for research, training and education programs to promote the prevention and treatment of heart, lung and blood diseases. Previously, Dr. Gibbons was founding director of the Cardiovascular Research Institute, and professor of physiology and medicine at Atlanta's Morehouse School of Medicine. He has received several patents for innovations derived from his research in vascular biology and the pathogenesis of vascular diseases.

Dr. Roger I. Glass
Director, Fogarty International Center, NIH
Associate Director for Global Health Research, NIH
A renowned diarrheal disease expert, Dr. Roger I. Glass has led the Fogarty International Center since 2006. In addition to managing Fogarty's research and training programs, Dr. Glass advises the NIH Director on global health issues. During his long career, he has helped develop several rotavirus vaccines, including a new one being manufactured in India that is available for one dollar per dose. Dr. Glass, who has also served with the CDC, has maintained field studies in India, Bangladesh, Brazil, Mexico, Israel, Russia, Vietnam, China and elsewhere. He is fluent and often lectures in five languages.

^ Agenda

Dr. Satish Gopal
Assistant Professor, University of North Carolina
Cancer Program Director, UNC Project-Malawi
A former Fogarty grantee and Fellow, Dr. Satish Gopal is Malawi's only board-certified medical oncologist. An assistant professor at the University of North Carolina at Chapel Hill, he directs the cancer program of the UNC Project-Malawi, a long-term collaboration between UNC and the Malawi Ministry of Health. Dr. Gopal is a lead investigator on a National Cancer Institute (NCI) grant that funds the UNC-Malawi Cancer Consortium, which is studying the growing worldwide cancer problem and expanding the university's efforts in Malawi to research HIV-associated cancers.

Dr. Glenda Gray
Chair, Global Alliance for Chronic Diseases
President and CEO, South African Medical Research Council
Dr. Glenda Gray is known for her expertise in prevention of mother-to-child transmission of HIV, adolescent HIV prevention and treatment, and HIV vaccine and microbicide research. A former Fogarty trainee, she is CEO and president of the South African Medical Research Council and chairs the board of the Global Alliance for Chronic Diseases. She co-founded the internationally recognized Perinatal HIV Research Unit in Soweto, South Africa, and is co-principal investigator of the HIV Vaccine Trials Network.

Dr. Richard J. Hodes
Director, National Institute on Aging, NIH
Dr. Richard J. Hodes, a leading researcher in the field of immunology, has been director of NIH's National Institute on Aging (NIA) since 1993. The NIA supports and conducts research on the biological, clinical, behavioral and social aspects of aging. Dr. Hodes also directs the federal effort to find effective ways to treat or prevent Alzheimer's disease. Studies in genetics, basic mechanisms, imaging and biomarkers have spurred the development of potential therapies aimed at a variety of targets and the testing of interventions at the earliest signs of disease.

^ Agenda

Dr. Richard Horton
Editor, The Lancet
A provocative lecturer, Dr. Richard Horton has been with The Lancet medical journal since 1990, continuing its mission to address urgent topics in society, initiate debate, put science into context, and influence decision makers around the world. Dr. Horton was the first president of the World Association of Medical Editors and is a past president of the U.S. Council of Science Editors. He is an honorary professor at the London School of Hygiene and Tropical Medicine, University College London, and the University of Oslo.

Dr. Mark Kaddumukasa
Senior Lecturer, Makerere University College of Health Sciences, Uganda

A physician in Uganda whose research interests include epilepsy, Dr. Mark Kaddumukasa holds positions with Makerere University College of Health Sciences and Mulago National Teaching and Referral Hospital. With a grant through Fogarty’s Emerging Global Leader program, Dr. Kaddumukasa is studying seizure frequency, quality of life and stigma reduction in people living with epilepsy, and has mentors at Makerere and University Hospitals of Cleveland. His Fogarty grant is partially supported by NIH's National Institute of Neurological Disorders and Stroke (NINDS).

Dr. Peter Kilmarx
Deputy Director, Fogarty International Center, NIH
An expert in infectious disease research and HIV/AIDS prevention, Dr. Peter Kilmarx has served as deputy director of NIH's Fogarty International Center since 2015. Previously, he was the CDC's country director in Zimbabwe, providing oversight for 30 staff who managed implementation of the U.S. efforts to reduce HIV/AIDS, TB and malaria. A Rear Admiral in the U.S. Public Health Service, Dr. Kilmarx served as the CDC Ebola response team leader in Sierra Leone in 2014, and as principal deputy team leader in Guinea in 2015. He began his international career as a Peace Corps volunteer.

^ Agenda

Dr. Walter J. Koroshetz
Director, National Institute of Neurological Disorders and Stroke, NIH
Dr. Walter J. Koroshetz has been director of NIH's National Institute of Neurological Disorders and Stroke (NINDS) since 2015. Dr. Koroshetz joined the Institute as its deputy director in 2007 and has held leadership roles in a number of NIH and NINDS programs including the NIH's BRAIN Initiative and the Traumatic Brain Injury Center, a collaborative effort between the NIH intramural program and the Uniformed Health Services University. Before coming to NIH, he was a professor of neurology at Harvard University and vice chair of neurology at Massachusetts General Hospital.

Dr. Kenneth S. Kosik
Professor, University of California, Santa Barbara
Since 2004, Dr. Kenneth S. Kosik has been co-director of the Neuroscience Research Institute and the Harriman chair in the Department of Molecular, Cellular and Developmental Biology at the University of California, Santa Barbara. Dr. Kosik has been collaborating with Colombian scientists since the 1990s, studying an extended family with inherited early-onset Alzheimer's Disease. With Fogarty funding, he trained a number of Colombian scientists, creating the local capacity required to support an ongoing National Institute on Aging (NIA) drug trial to see if the disease can be stopped in its earliest stages.

Dr. Douglas R. Lowy
Deputy Director, National Cancer Institute, NIH
Dr. Douglas R. Lowy was named deputy director of NIH's National Cancer Institute (NCI) in 2010 and served as acting director from April 2015 until October 2017. Research by Dr. Lowy and fellow NCI scientist Dr. John T. Schiller helped produce vaccines against human papillomavirus (HPV) infection, which causes cervical cancer. A finding from clinical trials in Costa Rica that two doses of the HPV vaccine are effective has been adopted as standard-of-care in the U.S. Drs. Lowy and Schiller have received high honors for their research, including a 2017 Lasker Award.

^ Agenda

Dr. Julie Makani
Associate Professor and Principal Investigator, Sickle Cell Programme, Muhimbili University of Health and Allied Sciences, Tanzania
Dr. Julie Makani is an associate professor in the Department of Hematology and Blood Transfusion at Muhimbili University, the main clinical, academic and research centre in Tanzania, where she is the principal investigator of the sickle cell disease program. Dr. Makani and colleagues intend to use sickle cell disease as a model to establish scientific and technological solutions that are locally relevant but have global significance. She is a National Heart, Lung and Blood Institute (NHLBI) grantee.

Dr. Vivek Naranbhai
Resident Physician, Massachusetts General Hospital
Clinician-scientist Dr. Vivek Naranbhai's work spans immunology, genetic epidemiology and bioinformatics in a range of infectious diseases, chiefly HIV and tuberculosis. A former Fogarty Fellow and a research associate with the Centre for the AIDS Programme of Research (CAPRISA) in South Africa, Naranbhai is currently a resident physician at Massachusetts General Hospital and honorary senior lecturer at the University of KwaZulu-Natal.

Dr. Vishwajit Nimgaonkar
Professor, University of Pittsburgh
Dr. Vishwajit Nimgaonkar is director of the Program for Genetics and Psychosis, and professor of psychiatry and human genetics at the University of Pittsburgh. His research focuses on the cause of severe psychiatric illnesses, including genetic and environmental factors. With support from Fogarty and the National Institute of Mental Health (NIMH), he is conducting research training in Egypt and India to further genomic studies of - and find novel, effective interventions for - psychiatric illness such as schizophrenia, a noncommunicable disorder that ranks in the top 25 causes of disability worldwide.

Dr. Bill Pape
Director, GHESKIO, Haiti
A former Fogarty trainee and longtime grantee, Dr. Bill Pape established GHESKIO Centers in Haiti in 1982 to study the outbreak of an infectious disease that later became known as HIV/AIDS. With Fogarty support, Pape has trained scores of scientists who are at the forefront of HIV/AIDS and TB research and treatment in Haiti. In addition to leading GHESKIO, Dr. Pape is a professor of medicine at Weill Cornell Medicine, part of Cornell University, his alma mater.

^ Agenda

Dr. Sam Phiri
Director and Principal Investigator, Lighthouse Trust Clinic, Malawi
A former Fogarty trainee, Dr. Sam Phiri now trains and mentors a new generation of scientists in Malawi. He also obtains funding and manages clinical trials - all while running his country's largest HIV care organization, Lighthouse Trust, which handles more than 18,000 HIV and AIDS patients. Dr. Phiri is a lead investigator on a National Cancer Institute (NCI) grant funding the UNC-Malawi Cancer Consortium, which is developing capacity and conducting research on HIV-associated cancers.

Dr. Nelson Sewankambo
Professor, Makerere University, Uganda
Dr. Nelson Sewankambo, a longtime Fogarty grantee, is former principal of Uganda's Makerere University College of Health Sciences and dean emeritus of its School of Medicine. He has played a key role in implementing capacity building under the Medical Education Partnership Initiative (MEPI), administered by Fogarty. Dr. Sewankambo co-founded Uganda's Rakai Health Sciences Program, which has produced key HIV/AIDS research findings, including that male circumcision reduces HIV transmission. His team has pioneered multidisciplinary education capacity and the use of information technologies and innovations.

Dr. Sten H. Vermund
Dean, Yale University School of Public Health
A pediatrician and infectious disease epidemiologist, Dr. Sten H. Vermund is a longtime Fogarty grantee whose work has focused on HIV implementation and prevention science research. He has trained numerous scientists in Zambia, China, India, Pakistan and Mozambique and previously managed the Fogarty Scholars and Fellows program. His work on HIV-HPV interactions among women in methadone programs in the Bronx motivated a change in the 1993 CDC AIDS case surveillance definition and inspired cervical cancer screening programs launched within HIV/AIDS programs around the world.

^ Agenda

Updated: May 16, 2018

Footer